Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Nonproliferative”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Study completedNCT03197870
What this trial is testing

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 167
Not applicableUnknownNCT01790945
What this trial is testing

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

Who this might be right for
Mild Nonproliferative Diabetic RetinopathyModerate Nonproliferative Diabetic RetinopathySevere Nonproliferative Diabetic Retinopathy+2 more
Retina Institute of Hawaii 500
Not applicableUnknownNCT03863535
What this trial is testing

PRP vs PRP+IVC for Severe nPDR

Who this might be right for
Severe Nonproliferative Diabetic RetinopathyDiabetic RetinopathyDiabete Mellitus
Ruijin Hospital 40
Large-scale testing (Phase 3)Study completedNCT02718326
What this trial is testing

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
Regeneron Pharmaceuticals 402
Large-scale testing (Phase 3)UnknownNCT04511715
What this trial is testing

Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy
Shahid Beheshti University of Medical Sciences 100
Large-scale testing (Phase 3)Ended earlyNCT00600262
What this trial is testing

Intravitreal Bevacizumab for Diabetic Retinopathy

Who this might be right for
Severe NonproliferativeProliferative Diabetic RetinopathyActive Photocoagulated Diabetic Retinopathy
Asociación para Evitar la Ceguera en México
Testing effectiveness (Phase 2)Study completedNCT05383209
What this trial is testing

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 77
Testing effectiveness (Phase 2)UnknownNCT04782128
What this trial is testing

Evaluation of RC28-E Injection in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
RemeGen Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00511875
What this trial is testing

Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Thomas Gardner 30
Early research (Phase 1)UnknownNCT05695417
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy
Ocular Therapeutix, Inc. 21